This is nevertheless consistent with other post-mortem studies that reported no change in mRNA and protein expression of NLRP3, as well as mRNA expression of PYCARD and CASP1 in AD [22,23,38] (Table 1). This evidence concerns the gene CASP1 and Alzheimer disease.